Rv1129c - p.Val116Phe
Drug resistance types
7 Sensitive
1 RR-TB
2 HR-TB
15 MDR-TB
4 Pre-XDR-TB
0 XDR-TB
0 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.1.2.1 | 1 |
| lineage4.3.4.2.1 | 11 |
| lineage4.8 | 2 |
| lineage4.6.1.2 | 1 |
| lineage2.2.1 | 1 |
| lineage4.2.1 | 5 |
| lineage4.6 | 1 |
| lineage4.4.2 | 2 |
| lineage4.4.1.1 | 2 |
| lineage1.1.3.2;lineage4.3.4.2.1 | 1 |
| lineage1.1.3.1 | 1 |
| lineage4.2.2.2 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 29 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR1166189 | Pre-XDR-TB | lineage4.1.2.1 | ro | ERR181986 | MDR-TB | lineage4.3.4.2.1 | mw | ERR4811135 | Sensitive | lineage4.8 | cn | ERR551359 | Sensitive | lineage4.6.1.2 | cg | SRR25207170 | Pre-XDR-TB | lineage2.2.1 | None | ERR190370 | MDR-TB | lineage4.3.4.2.1 | mw | ERR2513608 | MDR-TB | lineage4.2.1 | gb | SRR24783284 | RR-TB | lineage4.6 | None | ERR036188 | MDR-TB | lineage4.3.4.2.1 | mw | ERR4811163 | Pre-XDR-TB | lineage4.4.2 | cn | ERR037486 | MDR-TB | lineage4.3.4.2.1 | mw | SRR29274285 | MDR-TB | lineage4.8 | None | ERR11050286 | Sensitive | lineage4.4.1.1 | None | ERR11050306 | Sensitive | lineage4.4.1.1 | None | ERR176616 | MDR-TB | lineage1.1.3.2;lineage4.3.4.2.1 | mw | ERR221616 | MDR-TB | lineage4.3.4.2.1 | mw | SRR7645798 | Sensitive | lineage4.2.1 | None | SRR10726049 | HR-TB | lineage1.1.3.1 | None | ERR221617 | MDR-TB | lineage4.3.4.2.1 | mw | ERR181861 | MDR-TB | lineage4.3.4.2.1 | mw | SRR7755728 | Sensitive | lineage4.2.1 | None | SRR7755736 | Sensitive | lineage4.2.1 | None | SRR7069713 | MDR-TB | lineage4.2.1 | None | ERR11081118 | HR-TB | lineage4.2.2.2 | None | ERR1063848 | MDR-TB | lineage4.3.4.2.1 | None | ERR163958 | MDR-TB | lineage4.3.4.2.1 | mw | ERR176629 | MDR-TB | lineage4.3.4.2.1 | mw | ERR221618 | MDR-TB | lineage4.3.4.2.1 | mw | SRR25207080 | Pre-XDR-TB | lineage4.4.2 | None |
|---|
